Adriamycin News and Research

RSS
New technique measures how well cancer drugs reach their targets

New technique measures how well cancer drugs reach their targets

Inhibiting immune-regulating molecule could prevent or reverse renal injury, research shows

Inhibiting immune-regulating molecule could prevent or reverse renal injury, research shows

Researchers propose new treatment strategy for colon cancer patients

Researchers propose new treatment strategy for colon cancer patients

Chemotherapy drug combination appears to increase production of eggs in women's ovaries

Chemotherapy drug combination appears to increase production of eggs in women's ovaries

Chances of survival due to chemotherapy significantly lower for older breast cancer patients

Chances of survival due to chemotherapy significantly lower for older breast cancer patients

Resveratrol and quercetin may improve efficacy of existing chemotherapeutic cancer drug

Resveratrol and quercetin may improve efficacy of existing chemotherapeutic cancer drug

Combination therapy can reduce recurrence of small, HER2-positive breast tumors

Combination therapy can reduce recurrence of small, HER2-positive breast tumors

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

Women with HER2+ breast tumors who receive combination therapy unlikely to have cancer recur

Women with HER2+ breast tumors who receive combination therapy unlikely to have cancer recur

New drug combination therapy effective for patients with HER2-positive breast cancer

New drug combination therapy effective for patients with HER2-positive breast cancer

Pediatric Hodgkin lymphoma can be treated without radiation and intensive chemotherapy

Pediatric Hodgkin lymphoma can be treated without radiation and intensive chemotherapy

Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective

Normal p53 gene makes breast cancer chemotherapy with doxorubicin less effective

Herceptin chemo combination could mean longer survival and lower side effects in breast cancer patients: Study

Herceptin chemo combination could mean longer survival and lower side effects in breast cancer patients: Study

BSD announces inclusion of hyperthermia and chemotherapy for high-risk sarcoma cancer patients

BSD announces inclusion of hyperthermia and chemotherapy for high-risk sarcoma cancer patients

Researchers find breast cancer therapy contributes to early-in-life hip fractures in women

Researchers find breast cancer therapy contributes to early-in-life hip fractures in women

Research reveals new standard treatment options for various forms of lymphoma

Research reveals new standard treatment options for various forms of lymphoma

Omeros identifies orphan GPCR compound that potentiates tumor-killing activity of doxorubicin

Omeros identifies orphan GPCR compound that potentiates tumor-killing activity of doxorubicin

Brentuximab vedotin-chemotherapy combination clinical trial for Hodgkin lymphoma announced

Brentuximab vedotin-chemotherapy combination clinical trial for Hodgkin lymphoma announced

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Researchers show how anthracycline class of chemotherapeutics block blood vessel growth, slow cancer spread

Researchers show how anthracycline class of chemotherapeutics block blood vessel growth, slow cancer spread